Replicel Life Sciences Inc V.RP

Replicel Ownership

[Ingiboy]

The following chart from Stockhouse "Ownership" (not sure how up to date this chart is but it gives you a pretty good snapshot of who controls Replicel) :

Top Investors

Name	% Held	Held	Held Change	Date	TurnOver
Schutte (Andrew)	26.77	17,401,616	0	2023-04-25	MED
Mackay (Jamie)	15.44	10,034,537	0	2023-04-25	MED
YOFOTO China Health Industry Co Ltd	8.24	5,357,900	0	2023-04-25	LOW
Mainpointe Pharmaceutical, L.L.C.	6.13	3,986,684	0	2023-04-25	LOW
McElwee (Kevin)	2.04	1,329,245	670,833	2022-12-31	LOW
Lowry (Peter)	1.84	1,193,426	0	2023-01-27
Hall (David M)	1.35	875,632	17,500	2023-02-01	LOW
Lewis (Peter W)	0.9375	609,420	-17,500	2023-01-27
Hoffman (Rolf)	0.7532	489,572	0	2022-12-31	LOW
Austring (Ben)	0.4931	320,500	320,500	2022-12-31

Non of these people or companies want to loose their investment and except for Ben have been long term investors so we need to have some faith in what they are doing. I just wish I knew a bit more about what is going on.  Any shred of positive news that gives me hope we won't loose our investment.

We move ever closer  to this latest saga coming to some conclusion.

[baldstock]

True! Only way they can get their money back is M&A. Hopefully RCH-01 succeed and big Pharma buy out the company. Some people say $20+ but ideally I think $3~$5 dollar range.  Even though RCH -01 succeed Replicel have not enough capital to commericalize.